Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 11 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Sol Gel Technologies Ltd | SLGL | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 0.8768 | 06:00:17 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.8768 |
| Trades | Shares Traded | Average Volume | 52 Week Range |
|---|---|---|---|
| 1 | 11 | - | 0.79 - 4.0498 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 07:00:00 | 11 | US$ 0.8448 | USD |
Sol Gel Technologies Ltd Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 24.51M | 27.86M | - | 1.61M | -27.24M | -0.98 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Sol Gel Technologies News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SLGL Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.92 | 0.99 | 0.86 | 0.8709608 | 22,977 | -0.0432 | -4.70% |
| 1 Month | 1.03 | 1.07 | 0.79 | 0.9333173 | 32,697 | -0.1532 | -14.87% |
| 3 Months | 1.24 | 1.50 | 0.79 | 1.03 | 30,210 | -0.3632 | -29.29% |
| 6 Months | 1.29 | 1.59 | 0.79 | 1.11 | 25,409 | -0.4132 | -32.03% |
| 1 Year | 3.60 | 4.0498 | 0.79 | 1.76 | 19,549 | -2.72 | -75.64% |
| 3 Years | 11.22 | 14.50 | 0.79 | 5.77 | 17,903 | -10.34 | -92.19% |
| 5 Years | 7.10 | 26.52 | 0.79 | 9.25 | 27,297 | -6.22 | -87.65% |
Sol Gel Technologies Description
| Sol-Gel Technologies Ltd is a clinical-stage specialty pharmaceutical company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications. |
